A systematic review of conversion factors between kerma-area product and effective/organ dose for cardiac interventional fluoroscopy procedures performed in adult and paediatric patients

The aim of this systematic review is to undertake a critical appraisal of the evidence in the published literature concerning the conversion factors between kerma-area product (P (KA)) and effective/organ dose (DCED_PKA, DCHT_PKA) for cardiac interventional fluoroscopy procedures performed in adults and paediatric patients and to propose reference conversion factors to help standardize dose calculations. A search strategy utilizing MeSH headings in three databases identified 59 (adult) and 37 (paediatric) papers deemed eligible for the review. Exclusion criteria were adopted to select data only from publications which established DCED_PKA in patients using the ICRP 103 tissue weighting factors. A time restriction from January 2007 was introduced in the search to capture the evolving trends of utilization of fluoroscopy-guided intervention technologies only in recent years. The suggested DCED_PKA and DCHT_PKA were synthesized by calculating the weighted averages of the values reported by the authors with weights corresponding to the study sample size. Eighteen studies for both adult (9) and paediatric (9) patients matching the search terms fulfilled the inclusion criteria. The suggested value for DCED_PKA in adult patients amounts to 0.24 mSv Gy(-1)cm(-2). The suggested values for DCHT_PKA ranged from a minimum of 0.15 mSv Gy(-1)cm(-2) for the female breast to a maximum of 0.97 mSv Gy(-1)cm(-2) for the lungs. The suggested values for DCED_PKA in paediatric patients ranged from 3.45 mSv Gy(-1)cm(-2) for the new-born to 0.49 mSv Gy(-1)cm(-2) in the 15 years age class. The suggested values for DCHT_PKA ranged from a minimum of 0.33 mSv Gy(-1)cm(-2) for bone marrow in the 15 years age class to a maximum of 11.49 mSv Gy(-1)cm(-2) for the heart in the new-born. To conclude, values of DCED_PKA/DCHT_PKA were provided for calculating effective/organ doses in cardiac interventional procedures. They can be useful for standardizing dose calculations, hence for comparison of the radiation detriment from different imaging procedures and in the framework of epidemiologic studies.

Automated summary

The aim of this systematic review is to critically appraise the evidence in the published literature regarding the conversion factors between kerma-area product (P(KA)) and effective/organ dose (DCED_PKA, DCHT_PKA) for cardiac interventional fluoroscopy procedures performed in adults and paediatric patients and propose reference conversion factors for standardizing dose calculations.